This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Fund Flows curates 5 articles on fund movements and stock signals, showing how inflows and selling pressure can move portfolios. Learn practical takeaways to refine risk and returns. Take action today
23 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
When a leading fund sells a sizable stake in a cyclical manufacturer after a rough quarter, investors want clarity. T...
A travel stock is down 38%, yet a prominent fund just added $24 million to its position. This article explains what t...
A sudden 47% rise in Structure Therapeutics stock has traders buzzing while a major fund exits a multi-million dollar...
A notable fund pulled out of a multi-million dollar DNOW position last quarter, triggering questions about strategy a...
A new multi-asset crypto strategy fund has drawn record inflows, earning the label this year’s hottest crypto play as...
A telecom stock this rose 19% over the past year, but a prominent fund sold out. Discover the drivers behind the move...
US-based crypto funds lead weekly inflows, pushing total crypto fund flows above $1 billion for a third straight week...
A payments stock down draws 30% on growth concerns while a small investor places a $6 million bet as revenue hits $4 ...
A major fund sold a sizable stake in Darling Ingredients, but the stock defied expectations and surged. This article ...
JPMorgan warns that retail investors showing signs of fatigue could temper stock demand as Iran-related tensions inte...
XRP ETFs have seen a wave of redemptions in March, yet industry analysts say the funds’ resilience remains intact as ...